Establishing a programme for continuous ambulatory infusion chemotherapy.
BACKGROUND
The development of venous access devices (VADs) and portable infusion pumps has enabled chemotherapy to be administered continuously within the home environment.


OBJECTIVE
The objective of this study was to describe the experience of establishing an ambulatory chemotherapy programme for patients receiving protracted infusions (PVIs) of 5-fluorouracil (5-FU).


METHODS
The files of all patients receiving PVI 5-FU as a component of their treatment for gastrointestinal malignancy were reviewed. The types of VADs, infusion pump systems and their management were documented. Information packages and education programmes were developed for patients.


RESULTS
Seventy-four patients with gastrointestinal cancer were studies. At the end of the period the Portacath was the preferred VAD, while both pumps used were found to have advantages and disadvantages. The choice of pump was decided more by patient preference than systematic differences in performance of the pumps.


CONCLUSIONS
The findings in this review confirm that, with close attention to the potential pitfalls of ambulatory chemotherapy, an acceptable service can be provided.
Cox
K
K
Department of Medical Oncology, Royal Prince Alfred Hospital, Sydney, NSW.
Visintin
L
L
Kovac
S
S
Childs
A
A
Kelleher
H
H
Murray
B
B
White
G
G
Storey
D
D
Findlay
M
M
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D015918:Infusion Pumps, Implantable / Q000009:adverse effects; D007262:Infusions, Intravenous / Q000295:instrumentation; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D005472:Fluorouracil